Comparison of99mTc(V)-DMSA,201Tl and99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid

Radionuclide scanning with tumour-seeking agents such as pentavalent technetium-99m dimercaptosuccinic acid [^99mTc(V)-DMSA], thallium-201 and technetium-99m sestamibi (MIBI) has been reported to be useful in the detection of medullary thyroid carcinoma (MTC). We undertook a study in 14 MTC patients to determine the comparative imaging potential of²⁰¹Tl, MIBI and^99mTc(V)-DMSA in the detection of recurrent or metastatic MTC. All patients underwent total thyroidectomy and had persistently elevated serum calcitonin levels after the surgery. Scintigraphic studies were carried out 20 min after the injection of 111 MBq of²⁰¹Tl or 555 MBq of MIBI and 2 h following the injection of 370 MBq of^99mTc(V)-DMSA. All scintigraphic findings were correlated with contemporaneous CT or MRI studies. CT, MRI and bone scans showed 42 (26 bone, 16 soft tissue) metastatic sites in 11 of the 14 patients. In the remaining three patients no lesions were detected during diagnostic evaluation.^99mTc(V)-DMSA showed all of the soft tissue metastases but could not show two bone lesions. On the other hand, MIBI imaging was false-negative in 22 (52%) sites and²⁰¹Tl was false-negative in 34 (80%) sites. Overall, lesion detection sensitivities for^99mTc(V)-DMSA, MIBI and²⁰¹Tl were 95%, 47% and 19% respectively. We conclude that^99mTc(V)-DMSA is clearly superior to MIBI and²⁰¹Tl in the follow-up of MTC patients.     

Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings

Early diagnosis of metastases of medullary thyroid carcinoma (MTC) provides the optimal condition for curative outcome. The aim of this study was to appraise the detection of metastases in patients with recurrent MTC using [¹¹¹In-DTPA-d-Phe¹]-pentetreotide and pentavalent technetium-99m dimercaptosuccinic acid [^99mTc(V)-DMSA] in comparison with histopathological findings. Eighteen MTC patients with persistently elevated tumour marker (calcitonin, carcinoembryonic antigen) levels underwent somatostatin receptor scintigraphy using [¹¹¹In-DTPA-d-Phe¹]-pentetreotide (222 MBq) with early (4 h after injection) and delayed (24 h) whole-body scans and single-photon emission tomography (SPET) imaging. Metabolic whole-body and SPET imaging using 500 MBq ^99mTc(V)-DMSA was performed 4 h after injection. Metabolic and receptor imaging revealed 51 sites of focal accumulation in the 18 patients investigated. Comparison with histological findings revealed that metabolic and receptor imaging had a sensitivity of 84% for the diagnosis of MTC. Using [¹¹¹In-DTPA-d-Phe¹]-pentetreotide, SPET discovered four lymph node metastases in two patients in whom planar views had previously identified only one lymph node metastasis, and provided no new information in the other 16 patients. In comparison, SPET studies [using ^99mTc(V)-DMSA] additionally localized eight lymph node metastases in four patients and confirmed the diagnosis of hepatic metastases (n=5) in another patient in whom conventional imaging modalities and planar views had previously detected only three liver metastases. Overall, lesion detection sensitivities for ^99mTc(V)-DMSA and [¹¹¹In-DTPA-d-Phe¹]-pentetreotide were 69% and 29%, respectively. Five surgically removed foci were adjudged false-positive with respect to MTC metastases. False-positve results were caused by lymphadenitis, an enchondroma and a pheochromocytoma (histologically proven). The smallest lesion identified by metabolic imaging was a 6 mm in diameter lymph node metastasis located in the upper mediastinum. Somatostatin receptor scintigraphy only demonstrated tumour sizes more than 1 cm in diameter. These preliminary results suggest that the combination of metabolic [^99mTc(V)-DMSA] and receptor ([¹¹¹In-DTPA-d-Phe¹]-pentetreotide) imaging is more sensitive for tumour localization in patients with recurrent MTC than the use of only one radiopharmaceutical. However, neither ^99mTc(V)-DMSA nor [¹¹¹In-DTPA-d-Phe¹]-pentetreotide is specific for MTC and false-positive scintigraphic findings have to be considered. Furthermore, somatostatin receptor scintigraphy cannot visualize small tumour sites (<1 cm). Further studies are needed to evaluate the role of combined metabolic and receptor imaging in the management of patients with recurrent MTC. Received 10 February and in revised form 20 May 1998     

Somatostatin receptor scintigraphy using <Superscript>99m</Superscript>Tc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma

Purpose Several new somatostatin analogues have been developed for the diagnosis and therapy of different tumours. Since somatostatin receptors are often over-expressed in medullary thyroid carcinoma (MTC), the aim of our study was to evaluate the utility of scintigraphy with the somatostatin analogue ^99mTc-EDDA/HYNIC-TOC in MTC in comparison with other diagnostic techniques. Methods Forty-five patients with MTC, aged 14–83 years, were investigated. Scintigraphy using ^99mTc-EDDA/HYNIC-TOC (Tektrotyd) was performed 2 and 4 h post injection of 740 MBq (20 mCi) of the tracer. Other imaging techniques were also applied and analysed in individual cases (ultrasonography, computed tomography, ^99mTc(V)-DMSA, ¹³¹I-MIBG, ^99mTc-MDP, ¹¹¹In-DTPA-octreotide and ¹⁸F-FDG-PET) and compared with ^99mTc-EDDA/HYNIC-TOC. Results In group 1 (eight patients before thyroidectomy), uptake of the tracer was found in the primary tumours. In group 2 (six patients with remission), a false positive result was found in one patient; in the remaining five patients, no pathological foci were visualised. In group 3 (31 patients with post-surgical hypercalcitoninaemia), scintigraphy was true positive in 23 patients (74.2%): uptake in the thyroid bed was found in five patients, in the lymph nodes in 18 and in bone metastases in four. Using ^99mTc-EDDA/HYNIC-TOC scintigraphy, the overall sensitivity was 79.5%, specificity 83.3%, accuracy 80.0%, positive predictive value 96.9% and negative predictive value 38.5%. Conclusion ^99mTc-EDDA/HYNIC-TOC is clinically useful for scintigraphy in the follow-up of patients with MTC. It can be used in clinical practice for preoperative evaluation, for localisation of local recurrence or distant metastases and particularly for therapy decision making.     

Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy,and serum thyroglobulin quantitation

Recently, technetium-99m methoxyisobutylisonitrile (^99mTc-MIBI) has been used to image thyroid carcinoma. A prospective study was performed to compare the efficacy of^99mTc-MIBI to thallium-201 (²⁰¹T1) scintigraphy in patients with differentiated thyroid carcinoma. The clinical utility of all radionuclide imaging modalities, i.e.,^99mTc-MIBI,²⁰¹Tl, and iodine-131 Na (¹³¹I-Na), as well as serum thyroglobulin estimation, was evaluated. Thirty-four post-thyroidectomy patients (age range: 26–76 years) underwent 45 studies. Histopathologies studied included fourteen papillary, eight papillaryfollicular, ten follicular, one Hürthle cell, and one medullary carcinoma of the thyroid. Following optimal stimulation of endogenous thyroid stimulating hormone (i.e, TSH >-50 mU/ml), the patients underwent²⁰¹Tl and^99mTc-MIBI scintigraphy. Concomitant¹³¹I-Na scintigraphy was performed and serum thyroglobulin levels were measured. Sixteen scan sets were performed prior to¹³¹I-Na ablation therapy. Twenty-nine scan sets were performed following¹³¹I-Na ablation therapy. The presence or absence of thyroid cancer was established by clinical, biochemical, radiologic, and/or biopsy findings. There was no significant difference in sensitivity and specificity of²⁰¹Tl scintigraphy versus^99mTc-MIBI scintigraphy in pre- and postablation studies.¹³¹I-Na scintigraphy with determination of thyroglobulin level was sufficient in preablation studies. Among postablation patients, the addition of^99mTc-MIBI or²⁰¹Tl offered a higher diagnostic yield. Between the²⁰¹Tl and^99mTc-MIBI studies, there was a concordance of 69% in preablation and 97% among postablation patients (P=0.027). It is concluded that^99mTc-MIBI is a suitable alternative to²⁰¹Tl scintigraphy in thyroid carcinoma, especially following thyroidectomy and¹³¹I-Na therapy.¹³¹I-Na scintigraphy with serum thyroglobulin is adequate in both pre- and postablation patients. Among the post-¹³¹I-Na ablation patients,^99mTc-MIBI or²⁰¹Tl is extremely valuable for tumor localization, especially when the¹³¹I-Na whole-body scan is negative. The combination of^99mTc-MIBI or²⁰¹Tl scintigraphy with¹³¹I-Na and serum thyroglobulin offers the highest diagnostic yield.This paper is based on a presentation at the 76th Annual Meeting of the American Radium Society, South Hampton, Bermuda, 22–26 April 1994.     

Pitfalls in scintigraphic detection of neuroendocrine tumours

We report 4 cases of abnormal results using iodine-123 metaiodobenzylguanidine (¹²³I-mIBG) or technetium-99m (V) dimercaptosuccinic acid (^99mTc(V)-DMSA) scintigraphy in the diagnosis and follow-up of presumed neuroendocrine tumours. The present series consisted of 2 false-positive cases (1 adenomatous polyp of the caecum with mIBG and 1 follicular adenoma of the thyroid with DMSA) and 2 cases of anomalous uptake of (V)-DMSA in a non-neuroendocrine tissue.Workin part presented at the International Congress G.R.A.D.O. 4 Rome, 10–11 May 1991 Offprint requests to: L. Feggi, 1, via Poledrelli, I-44100 Ferrara, Italy     

Clinical evaluation of 99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis

^99mTc(V)-DMSA kits developed by the Radiopharmaceutical Division, Bhabha Atomic Research Centre, have been evaluated for potential use in scanning medullary carcinoma of the thyroid and its metastases. There were 15 patients with proved medullary carcinoma and 6 patients with other differentiated thyroid carcinoma. Amongst the 15 patients with medullary carcinoma, 12(80%) showed positive localisation either in the primary or one or more metastatic sites. None of the six patients with carcinoma other than medullary showed increased concentration of ^99mTc (V)-DMSA. Of the 37 known metastatic sites in 15 patients with medullary carcinoma, 24 showed concentration of ^99mTc (V)-DMSA (64.9%). In addition, ^99mTc(V)-DMSA concentration was seen in 14 sites where no evidence of metastasis was revealed. The incidence of ^99mTc (V)-DMSA concentration in soft tissue and bone metastasis was similar.Isopharm, Radiopharmaceutical Division, BARC, Bombay-400 705, India     

Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy

We describe a simple method of pentavalent technetium-99m dimercaptosuccinic acid [^99mTc(V)-DMSA] preparation for the imaging of medullary carcinoma of the thyroid using commercially available kits. ^99mTc(V)-DMSA is available at high pH (approximately 7.5) by adding NaHCO₃ solution in the presence of a small amout of reducing agent (SnCl₂). On the other hand, trivalent ^99mTc-DMSA [^99m-Tc(III)-DMSA] can be obtained at low pH (below 3) in the presence of an excess amount of reducing agent. In the clinical evaluation of a patient with a medullary carcinoma of the thyroid, only ^99mTc(V)-DMSA revealed an area of intense accumulation.     

99mTc(V)-DMSA and67Ga-citrate images in a patient with recurrent extraabdominal fibromatosis

⁶⁷Ga-citrate and^99mTc(V)-DMSA images were obtained in a patient with recurrent extraabdominal fibromatosis of the left calf. The⁶⁷Ga-citrate image showed abnormal uptake in the left calf lesion and right calf, which was considered due to probable myositis caused by overexertion. On the other hand, the^99mTc(V)-DMSA image showed abnormal uptake only in the left calf lesion. Surgical and radiation therapy was performed. Two years after the treatment, two lesions of the recurrent extraabdominal fibromatosis followed, and a^99mTc(V)-DMSA image could demarcate the two lesions.^99mTc(V)-DMSA images were considered to be useful in following up of recurrent extraabdominal fibromatosis.     

Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours

Scintigraphy using [¹¹¹In-DTPA-d-Phe¹]-pentetreotide or pentavalent technetium-99m-dimercaptosuccinic acid [^99mTc(V)-DMSA] has been shown to localize well-differentiated and slowly growing neuroendocrine tumours, whereas increased fluorodeoxyglucose (FDG) uptake is associated with malignancy. The aim of this study was to compare the value of fluorine-18 FDG positron emission tomography (PET) with that of somatostatin receptor scintigraphy (SS-R) and dual-radionuclide scintigraphy [SS-R and ^99mTc(V)-DMSA = DNS] in detecting malignant neuroendocrine tumours. Fifteen patients with metastasizing gastroenteropancreatic tumours (GEP tumours; n = 7), medullary thyroid carcinomas (MTCs; n = 8) and elevated tumour markers [GEP tumours: 5-hydroxyindoleacetic acid, insulin; MTCs: calcitonin, carcinoembryonic antigen (CEA)] were studied. Prior to PET, all patients with GEP tumours underwent SS-R. DNS was performed in all patients with MTC. Patients had been fasting for at least 12 h and normal glucose plasma levels were confirmed. Sixty minutes after intravenous administration of ¹⁸F-FDG (mean: 374 MBq) whole-body PET and regional scans were performed. In addition, the resected tissues were prepared for immunocytochemistry examination (cell cycle-associated Ki-67 antigen). In two patients with less-differentiated GEP tumours associated with high proliferative activity and increased FDG uptake, SS-R failed to detect any lesion. In comparison, in four patients with well-differentiated GEP tumours showing low proliferative acitivity, SS-R localized four primary tumours, 22 lymph node metastases and 18 malignant liver lesions, whereas ¹⁸F-FDG PET demonstrated normal distribution. In one patient with a metastasizing carcinoid (medium proliferative activity) SS-R localized multiple metastases, whereas PET demonstrated low FDG uptake in all known metastases. In patients with recurrent MTC and rapidly increasing CEA levels DNS detected only three lesions in two patients, whereas PET demonstrated one pulmonary, three osseous, 20 mediastinal, ten locoregional, and four liver metastases in seven patients. Twenty-nine malignant lesions were confirmed by follow-up and nine lymph node metastases could be surgically removed. In conclusion, PET imaging of gastroenteropancreatic tumours revealed increased glucose metabolism only in less-differentiated GEP tumours with high proliferative activity and metastasizing MTC associated with rapidly increasing CEA levels. Therefore, additional ¹⁸F-FDG PET should be performed only if SS-R or DNS is negative. Received 8 July and in revised form 19 September 1997     

A method of simultaneous dual-radionuclide cardiac imaging with technetium 99m and thallium 201. I: Analysis of interradionuclide crossover and validation in phantoms

Background  

Simultaneous dual-radionuclide technetium 99m/thallium 201 scintigraphy can potentially produce perfectly aligned stress and rest images in less time than conventional protocols. However, interradionuclide crossover limits diagnostic accuracy. Accordingly, we evaluated^99mTc and²⁰¹Tl crossover in line and heart phantoms.     

New tracers for the imaging of the medullary thyroid carcinoma

I-MIBG and 99Tcm(V)-DMSA have been recently proposed as scintigraphic markers of the medullary thyroid carcinoma (MTC). Thirty two patients were examined with 131I- or 123I-MIBG and 26 of these were re-examined with 99Tcm(V)-DMSA (planar and SPECT). From our experience we can draw the following conclusions: (1) the scintigraphic attempt was useless in patients with normal levels of plasma calcitonin (CT): (2) in patients with high plasma CT levels, the sensitivity of the MIBG was better in familiar (3/3 true positive) than in sporadic disease (7/21 true positive; overall sensitivity = 42%); the 99Tcm(V)-DMSA was positive in 16/19 cases, (overall sensitivity = 84%) even in cases which had been false negative with MIBG (6 patients); (3) no false positive results were found; (4) the scan with 99Tcm(V)-DMSA is then suggested as the first imaging approach during the follow up in patients affected by MTC and still having high levels of plasma CT. The MIBG scan should be limited to the patients in whom the possible use of MIBG therapy has to be investigated.     

Thyroid imaging in a typical case of acute suppurative thyroiditis with abscess formation due to infection from a persistent thyroglossal duct

The clinical evaluation of thyroid imaging with^99mTc,²⁰¹T1, and⁶⁷Ga in the uncommon, but potentially serious, disorder of acute suppurative thyroiditis (AST) with abscess formation due to infection from a persistent thyroglossal duct is reported. The^99mTc image showed functioning areas of the diseased thyroid gland and the²⁰¹Tl image demonstrated abscess formation in the thyroid gland of this patient. In addition, marked⁶⁷Ga accumulation was demonstrated in a wide area covering not only the area of the thyroid gland involved, but also associated circumferential inflammatory lesions in a patient with AST. The net thyroid uptake of⁶⁷Ga at 72 hours was calculated to be 13.8% of the injected dose.     

A comparison of 99mTc and 123I scintigraphy in nodular thyroid disorders

Out of 450 patients referred for thyroid scintigraphy 83 consecutive patients with nodular goitre were selected for dual scintigraphy with ^99mTc and ¹²³I. Seventy-four patients had one or more palpable nodules and the other nine patients had palpably diffuse goitres with one or more nodules on the routine ^99mTc scintigram. For the comparison of scintigrams an eight level colour display was used, and regional differences between the ^99mTc and ¹²³I scintigrams were defined as a minimum of 25% (2 colour levels) variation of the relative activity in well defined areas.Thirteen patients, i.e. 16% of those with nodular goitre, had discordant scintigrams. All 13 patients had non-malignant thyroid disorders, (simple goitre, radio-iodine treated hyperthyroidism, autonomous adenoma, subacute thyroiditis, Riedel's and lymphocytic thyroiditis). The diagnosis was verified histologically in eight of these patients.Eight of the 13 patients had a high ^99mTc activity relative to ¹²³I, five patients showed the opposite discrepancy. Another 5 patients with a follicular or mixed follicular thyroid carcinoma had identical scintigrams.These findings indicate that ¹²³I does not offer such diagnostic advantages over the cheap and readily available ^99mTc, that its use for routine scintigraphy of the thyroid gland seems to be justified at present.     

Comparison of reinjection thallium 201 and resting technetium 99m sestamibi tomographic images for the quantification of infarct size after acute myocardial infarction

Background

Both thallium 201 and technetium 99m sestamibi have been used to quantitate infarct size at rest. Exercise²⁰¹Tl scintigraphy has been shown to have powerful prognostic information after myocardial infarction. A single study using these agents that could provide data on infarct size and prognosis would be of value. The purpose of this study was to compare estimates of infarct size by use of²⁰¹Tl and^99mTc sestamibi and to correlate these measurements with left ventricular ejection fraction in patients after acute myocardial infarction.

Methods and Results

The study group consisted of 20 patients who underwent low-level²⁰¹Tl stress studies with reinjection and^99mTc sestamibi resting studies within 4 days. Acute reperfusion was attempted in 18 of 20 patients. For^99mTc sestamibi tomographic imaging, infarct size was quantitated with 60% of maximal counts per slice for five short-axis slices as described in multiple previous studies. The postreinjection delayed²⁰¹Tl images acquired 4 hours after stress were quantitated according to the same threshold method.²⁰¹Tl patient images were also quantitated with a commercially available polar map program and compared with sex-matched control subjects. Ejection fraction was determined for each patient by radionuclide ventriculography 6 weeks later. Ejection fraction was well preserved for the group: mean 0.53±0.10. Infarct size with^99mTc sestamibi was 12%±13% of the left ventricle, which was significantly smaller than either method with²⁰¹Tl: threshold method, 29%±18% of left ventricle; polar map method, 25%±17% of left ventricle (both²⁰¹Tl estimates,p<0.0001 vs^99mTc sestamibi;²⁰¹Tl, 70% threshold vs²⁰¹Tl polar map,p=0.04). There was a significant correlation between infarct size with^99mTc sestamibi and that with²⁰¹Tl (r=0.72 to 0.73;p<0.001). Infarct size with^99mTc sestamibi, however, provided the closest correlation with ejection fraction (r=0.81;p<0.001), with the two²⁰¹Tl quantitative methods providing very similar correlations (r=0.69;p<0.001).

Conclusions

Infarct size with reinjection²⁰¹Tl imaging correlates significantly with resting infarct size with^99mTc sestamibi, although it provides significantly larger estimates. Although both approaches can be combined with a same-day exercise protocol, the closer correlation of infarct size with ejection fraction at 6 weeks suggests that resting infarct size with^99mTc sestamibi may be slightly more accurate.     

Simultaneous dual-isotope technetium-99m/thallium-201 cardiac SPET imaging using a projection-dependent spilldown correction factor

A spilldown correction method is proposed for the thallium-201 window image in simultaneous dual-isotope technetium-99m/thallium-201 single-photon emission tomographic (SPET) imaging based on a single acquisition into three energy windows. In this method, images are simultaneously acquired in two standard energy windows over the^99mTc and²⁰¹Tl photopeak regions and a third spilldown window adjacent to the²⁰¹Tl window. Using a Monte Carlo simulation of SPET, the fractional amount of^99mTc and²⁰¹Tl spilldown in the²⁰¹Tl window with respect to the total counts from the spilldown window, k12, was calculated for simulated images of point sources at varying depths within a water-filled elliptical tub phantom. When applied to experimental acquisitions, k12, multiplied by the total counts from the spilldown window, is then subtracted from the²⁰¹Tl window image to produce the corrected image. However, for successful applications in SPET, k12 must be determined on a projection-by-projection basis since k12 is depth dependent. Thus, a regression relation was obtained between k12 and the total count ratio of the spilldown to^99mTc windows, k23. The spilldown correction method was applied to²⁰¹T1 photopeak images of an extended source distribution in uniform and nonuniform attenuating media with dual-isotope^99mTc/²⁰¹Tl and single-isotope²⁰¹Tl. A marked improvement in image contrast was observed between the corrected and uncorrected²⁰¹Tl window images. The average count ratio of uncorrected dual-isotope²⁰¹Tl/single-isotope²⁰¹Tl was 3.08 for uniform and 2.99 for non-uniform attenuating media. When corrected, this value approached unity (0.97 and 1.08) and the corrected dual-isotope images were visually similar The presented method in which spilldown correction for the²⁰¹Tl photopeak window is performed in a single acquisition on a projection-by-projection basis in simultaneous dual-isotope SPET imaging could form the basis for a rapid and accurate clinical dual-isotope protocol independent of radiotracer administration.     

Simultaneous dual-isotope imaging based on an artificial neural network for evaluating myocardial perfusion and fatty acid metabolism

Background

We contrived a scatter correction method based on an artificial neural network (ANN) and applied it to the simultaneous evaluation of myocardial perfusion and fatty acid metabolism in single-photon emission computed tomography (SPECT).

Methods

The count data of three energy windows were used as inputs of the ANN. The count ratios of the estimated primary-to-total photons for ^99mTc and ¹²³I, which were used to reconstruct ^99mTc and ¹²³I images, were calculated using the ANN. In a phantom study, single- and dual-isotope imaging with ^99mTc/¹²³I and ²⁰¹Tl/¹²³I was performed by means of a cardiac phantom simulating patients with and without obesity. In a human study, five normal volunteers and ten patients with myocardial infarction underwent myocardial perfusion and fatty acid metabolism imaging with single and dual SPECT with combinations of ^99mTc-methoxyisobutylisonitrile/¹²³I-beta-methyl(p-iodophenyl)pentadecanoic acid (BMIPP) and ²⁰¹Tl/¹²³I-BMIPP as tracers.

Results

Technetium-99m yielded more homogeneous images than ²⁰¹Tl because of the lower degree of photon attenuation, especially in the condition of obese patients, resulting in clearer visualization of the perfusion-metabolism mismatch. Dual ^99mTc/¹²³I SPECT offered comparable images with single SPECT in assessing myocardial damage.

Conclusions

The method effectively separated ^99mTc and ¹²³I primary photons and proved applicable to ^99mTc/¹²³I dual-isotope myocardial SPECT.     

Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with 99mTc-MIBI, 201Tl, MRI and US

The aim of this study was to evaluate the efficacy and role of technetium-99m tetrofosmin for the detection of abnormal parathyroid glands to be referred for surgical treatment. Twenty-eight consecutive patients, including 25 primary and 3 secondary cases of hyperparathyroidism, were evaluated. ^99mTc-tetrofosmin/^99mTc-pertechnetate subtraction scintigraphy (TF/Tc) was performed on all patients, and the results were directly compared with those of ^99mTc-methoxyisobutylisonitrile (MIBI)/^99mTc-pertechnetate subtraction scintigraphy (MIBI/Tc), ²⁰¹Tl/^99mTc-pertechnetate subtraction scintigraphy (Tl/Tc), magnetic resonance imaging (MRI) and ultrasonography (US). In cases of single-gland disease, the sensitivities of TF/Tc, MIBI/Tc, Tl/Tc, MRI and US were 63.2%, 68.4%, 57.9%, 55.6% and 63.2%, respectively. In cases of multi-gland disease, the sensitivities of TF/Tc, MIBI/Tc, Tl/Tc, MRI and US were 41.7%, 41.7%, 37.5%, 58.3% and 54.2%, respectively. In cases of parathyroid adenoma, the sensitivities of TF/Tc, MIBI/Tc, Tl/Tc, MRI and US were 68.8%, 75.0%, 68.8%, 62.5% and 75.0%, respectively. In cases of parathyroid hyperplasia, the sensitivities of TF/Tc, MIBI/Tc, Tl/Tc, MRI and US were 40.7%, 40.7%, 33.3%, 53.8% and 48.1%, respectively. It is concluded that, for the detection of abnormal parathyroid glands, ^99mTc-tetrofosmin is as useful as ^99mTc-MIBI and is more useful than ²⁰¹Tl.     

Left ventricular dysfunction in coronary artery disease: Comparison between rest-redistribution thallium 201 and resting technetium 99m methoxyisobutyl isonitrile cardiac imaging

Background

We compared rest-redistribution thallium 201 and resting technetium 99m methoxyisobutyl isonitrile (MIBI) cardiac imaging in 29 men with angiographically proven coronary artery disease and regional ventricular dysfunction. Left ventricular ejection fraction at radionuclide angiography was 35%±9%.

Methods and Results

Regional left ventricular wall motion was assessed on gated^99mTc MIBI images according to a 3-point scale (0=normal, 1=hypokinetic, 2=akinetic or dyskinetic).²⁰¹Tl and^99mTc MIBI uptake values were analyzed quantitatively. A total of 435 myocardial segments were classified on the basis of wall motion analysis into three groups: group 1 (normal wall motion;n=201), group 2 (hypokinetic;n=132), and group 3 (akinetic or dyskinetic;n=102).²⁰¹Tl and^99mTc MIBI uptake values were significantly higher in groups 1 and 2 compared with group 3 (p<0.05) and in group 1 compared with group 2 (p<0.05). When²⁰¹Tl and^99mTc MIBI uptake values were directly compared, no significant differences in groups 1 and 2 were observed. In group 3,^99mTc MIBI uptake (67%±14%) was significantly lower (p<0.001) than initial (72%±11%) and delayed²⁰¹Tl uptake (73%±12%).

Conclusion

Thus rest-redistribution²⁰¹Tl and resting^99mTc MIBI cardiac imaging reflect the severity of left ventricular dysfunction in coronary artery disease. However, in segments with severely impaired regional ventricular function,²⁰¹Tl uptake is significantly higher than^99mTc MIBI uptake.     

Absent myocardial I-123 BMIPP uptake in a family

A 72-year-old woman with hypertension showed no sign of myocardial accumulation of¹²³I-BMIPP, and²⁰¹Tl and¹²³I-MIBG scintigraphy demonstrated normal findings. Electrocardiography showed left axis deviation with inverted T waves in leads I, aV_L, V_2–6 and QT prolongation. Coronary arteriography, two dimensional echo cardiography and laboratory data showed no abnormality. Her 66-year-old sister with non-insulin-dependent diabetes mellitus also had no myocardial BMIPP uptake, but had normal²⁰¹Tl finding. ECG and chest film findings were normal. Laboratory data indicated slightly high fasted blood glucose, triglyceride and total cholesterol. Four sons of a 72-year-old woman also underwent BMIPP scintigraphy. No BMIPP uptake was also observed in her 2nd son (49 years old) and his electrocardiogram showed QT prolongation. Since these rare findings indicating no myocardial BMIPP uptake were seen in a family, we suspected that a hereditary myocardial metabolic abnormality accounted for them.     

Paradoxical technetium-thallium subtraction scan in a case of parathyroid adenoma

A technetium-thallium (^99mTcO₄-²⁰¹Tl) subtraction scan was performed in a patient with clinical and biological evidence of hyperparathyroidism. The ²⁰¹Tl image indicated a normal thyroid gland. The ^99mTcO₄ image revealed a left inferior thyroidal extension with an intense and transient focus corresponding to an ultrasonographic nodule. The transient character of the focus was not explicable in terms of vascular kinetics. A supplementary scintigram using ¹²³I confirmed the presence of an inferior extension of the thyroid, but no increased uptake was found. A nodule weighing 250 mg containing a parathyroid adenoma surrounded by normal thyroidal tissue was excised at the focus site. Biological serum levels returned to normal after the operation. It is concluded that the analysis of ^99mTcO₄ dynamic data could improve the accuracy of parathyroid subtraction scintigraphy.